1. Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl med off Publ Soc Nucl Med. 1999;40(1):205–12.
2. Langen K-J, Stoffels G, Filss C, Heinzel A, Stegmayr C, Lohmann P, et al. Imaging of amino acid transport in brain tumours: positron emission tomography with O-(2-[ 18 F]fluoroethyl)- L -tyrosine (FET). Methods. 2017;130:124–34
3. Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl med off Publ Soc Nucl Med 1999;40(8):1367–1373.
4. Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncologia. 2016;18(9):1199–208.
5. Lammertsma AA. Tracer kinetic modelling. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Leenders KL. PET and SPECT in neurology [internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014 [cited 2017 Sep 26]. p. 59–73. Available from:
http://link.springer.com/10.1007/978-3-642-54307-4_3